Survival in treated hypertension: follow up study after two decades - Wikidata - wikimedia - TriplyDB

Survival in treated hypertension: follow up study after two decades

Survival in treated hypertension: follow up study after two decades

http://www.wikidata.org/entity/Q33814337

about

Polymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in Caucasians Multivariate risk assessment and risk score cards in hypertension Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study.Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.Thiazide diuretics in hypertension.British Hypertension Society guidelines for hypertension management 1999: summary Survival with treated and well-controlled blood pressure: findings from a prospective cohort study The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Essential hypertension: the heart and hypertension Carcinogenicity of antihypertensive therapy.Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure.Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study.Adverse socioeconomic position across the lifecourse increases coronary heart disease risk cumulatively: findings from the British women's heart and health study Association between childhood and adulthood socioeconomic position and pregnancy induced hypertension: results from the Aberdeen children of the 1950s cohort study.Hypertension treatment and stroke prevention.The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.Novel antihypertensive agents.Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?Long-term outcome of a large series of patients surgically treated for pheochromocytoma.Do angiotensin II antagonists provide benefits beyond blood pressure reduction?Angiotensin II-receptor antagonist in the treatment of hypertension.Hypertension in young children and neonates.Indapamide sustained release: a review of its use in the treatment of hypertension.The blood pressure lowering potential of sulodexide--a systematic review and meta-analysis Early detection and management of the high-risk patient with elevated blood pressure.Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment.Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials.The Canadian Hypertension Education Program--a unique Canadian initiative.Antihypertensive medications and their effects on lipid metabolism.Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Role of fetal programming in the development of hypertension.Antihypertensive treatment and stroke prevention: from recent meta-analyses to the PRoFESS trial.High blood pressure: An obscuring misnomer?The epidemiological concept of residual risk.Prevention of heart failure in the elderly: when, where and how to begin?Impact of Visit-to-Visit Variability in Systolic Blood Pressure on Cardiovascular Outcomes in Korean National Health Insurance Service-National Sample Cohort.Use of predictive markers to improve cardiovascular protection.The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population.Risk of coronary events by baseline factors during 28 years follow-up and three periods in a random population sample of men.

P2860

Q24813080-5D5FD8FF-01FB-41FD-BDE6-3F5DEB0235DF Q28219606-780E829D-3E0A-4861-8381-F50EEDB8E0B1 Q30234586-F35C631A-5D76-47F2-8A90-A26A65722A6B Q30234618-46CD7FEB-53C6-4C02-8CFB-0FC4647211E1 Q33697661-51DED536-3B70-4869-BE04-F9BB127E33B7 Q33797387-AD33485A-C064-4CA1-8CDC-77EFFBB9FA01 Q33886759-3078BA63-EB29-4F1A-A194-D19A46779E10 Q33955304-EACC8431-5C88-4D04-B8F6-BBA02D5959B5 Q34299778-F4EF3213-F3BE-444C-BAEE-AB86D8BEF52E Q34371136-50D3EB47-C3FA-4DA5-B31B-7E92AB676F5E Q34633329-C2D2BFEA-31B3-4890-83B1-5D992BCEA4E1 Q34634131-7AD0B52D-8132-4900-9E4B-49E6D65FE5A6 Q34874543-2B133323-09A2-4F27-B134-6518C10A592B Q35419752-4FA11DD3-2047-4BC7-B7F5-43D8B92159A6 Q35572114-A4836DA5-0E7C-4B04-B417-6F30F7969F81 Q35649169-5B2C0352-8CFF-45B2-92BA-A428F15E0544 Q35826150-6A3B13F0-79E5-4917-B67C-DD6E6970D9ED Q35842537-61F6A600-0E9B-4444-9D2C-7B1D134D86EF Q36060436-05E1E7F7-CFF3-4973-9F00-2BCBDBB6A82F Q36161460-B44CD206-9F1B-4A49-AD71-955749B8F70F Q36195282-79E6548B-633C-44B5-965D-8918CF562136 Q36214898-CB047A45-0F55-416B-BC4B-E4A38C6D101E Q36357069-C864151B-6858-4EA4-98D9-1C587CB51961 Q36383782-A0F4FFA0-6E3A-4153-9A85-54D4457A060E Q36410118-498A848D-C32A-4D27-9BDB-C08098B84620 Q36812763-4FDFD3D6-1FB0-4955-8996-35E2E087A1DF Q36836196-79C2D7B2-621C-44E1-B03A-338B1D59B28E Q36905137-77F15EE0-2908-49F1-B80E-E63102546AFA Q36921844-A0AABB6C-32AE-4ADA-A711-E89B5E616476 Q37215444-D96FA06C-453B-4A11-8DF0-BEC09291FC30 Q37253234-BB6AE4E9-44B1-465A-B6D0-A3F7A8AAE3F3 Q37297358-54DFD783-9A4F-44A1-93DC-8577D6ECDF30 Q37551262-E34BCFE4-D04D-4B11-9A21-10DD16D97F4C Q37672895-F8E435DE-A016-47C7-B76B-204D142E7303 Q37947160-70F4C205-B11C-40D9-954C-17D37927F7C1 Q37978190-ED6D68C1-C788-43F9-BFD3-DA0C0275E0A6 Q38774804-825029EF-72A6-4239-8116-53FFB2B5D0F5 Q40199205-9973DDA3-F6AE-46D6-9112-102D7ED044E6 Q44517758-6430C1D1-91DF-40E2-88E1-B905CACD7CBB Q45058811-8F550671-0A65-48F2-A4B0-9A19115BC26E

P2860

Survival in treated hypertension: follow up study after two decades

http://www.wikidata.org/entity/Q33814337

description

1998 nî lūn-bûn

@nan

1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Survival in treated hypertension: follow up study after two decades

@ast

Survival in treated hypertension: follow up study after two decades

@en

type

label

Survival in treated hypertension: follow up study after two decades

@ast

Survival in treated hypertension: follow up study after two decades

@en

prefLabel

Survival in treated hypertension: follow up study after two decades

@ast

Survival in treated hypertension: follow up study after two decades

@en

P1433

Q33814337-5C2DCDD6-0BD0-4EF1-8C7A-174E2A7A6192

P1476

Q33814337-84AC6773-4C10-4420-AD95-3BE1F9B0C37D

P2093

Q33814337-4ACBC96F-46E0-460A-85A3-3393307B9EE8

Q33814337-5B5D18C4-55DC-4AAF-91B4-B0F3546F3B8B

Q33814337-97DE1E63-29D5-40F8-9CBB-D2F9F26005DE

Q33814337-B92F36B5-6891-4F0C-9213-F6ECBB7DB151

Q33814337-DE16ACB9-EC4A-40C6-ABAE-0A049346B02E

P2860

Q33814337-137E1F63-AEB8-4625-B95F-932C442B4EE5

Q33814337-1647FA75-3FF4-4C10-B5A1-85B7169F85F1

Q33814337-40D10DDB-0DCF-4548-ADB1-FC6C0162AC55

Q33814337-6180F9D2-5571-473B-A2C9-BD123961C251

Q33814337-7A7FA1D3-3031-46A0-87D6-78DF2652F9D9

Q33814337-9A125072-C07A-44AF-A5C2-62639032D13A

Q33814337-A2AA6BCC-C55C-4903-B5EC-F8A11EF876E6

Q33814337-D157D25A-6CA4-4A88-8357-C1FCFFFE867B

Q33814337-DE4D03F1-D99E-4AA6-A0B1-F72E67B96DA6

Q33814337-E6D6C76E-2D69-43A6-B760-F806466A6808

P304

Q33814337-6DC10C4E-E889-4AB3-885F-FBB1A3A0F588

P31

Q33814337-58BFCB2E-A558-4E83-AF3F-B53863573D7B

P356

Q33814337-0BC2F23F-2027-44A2-9365-63D5FFBB73BA

P407

Q33814337-6ACCC00B-A791-4DEB-8A86-673C14F470D0

P433

Q33814337-6F11030E-44C6-4EED-9950-91E00147238A

P478

Q33814337-84CE4862-BFC0-4880-8FE6-D20099514766

P50

Q33814337-9851CB24-6BD0-4F59-99FC-A66E0A736D48

P577

Q33814337-9F84E177-4FC0-466C-8DEE-D25A57605605

P5875

Q33814337-60841F55-A6AC-42F2-ABC0-3CF4A7BD166C

P698

Q33814337-612543C9-D9F1-465A-B53B-6C201744655B

P932

Q33814337-CCA6121C-9383-4C53-B832-87FD1E80221C

P356

BMJ.317.7152.167

P1433

P1476

Survival in treated hypertension: follow up study after two decades

@en

P2093

L Wilhelmsen

http://www.w3.org/2001/XMLSchema#string

O K Andersson

http://www.w3.org/2001/XMLSchema#string

O Samuelsson

http://www.w3.org/2001/XMLSchema#string

T Almgren

http://www.w3.org/2001/XMLSchema#string

T Hedner

http://www.w3.org/2001/XMLSchema#string

P2860

Blood pressure, stroke, and coronary heart disease

Banting lecture 1988. Role of insulin resistance in human disease

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Adrenergic mechanisms in control of plasma lipid concentrations.

Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.

Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates.

Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project.

The prognosis of untreated and of treated hypertension and advantages of early treatment.

Metabolic disturbances in hypertension: results from the population study 'men born in 1913'.

P304

167-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.317.7152.167

http://www.w3.org/2001/XMLSchema#string

P407

P433

7152

http://www.w3.org/2001/XMLSchema#string

P478

317

http://www.w3.org/2001/XMLSchema#string

P50

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13618826

http://www.w3.org/2001/XMLSchema#string

P698

9665894

http://www.w3.org/2001/XMLSchema#string

P932

28606

http://www.w3.org/2001/XMLSchema#string